Mild Cognitive Impairment Due to Alzheimer's Disease Clinical Trials

12 clinical trials for Mild Cognitive Impairment Due to Alzheimer's Disease across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease — RECRUITING · PHASE3
• Autophagy-Enhancers to Reduce Sleep Disturbances — RECRUITING · NA
• Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease — RECRUITING · PHASE2
• UK Based Remote Brain Health Clinic (BHC) for Patients With Mild Cognitive Impairment (MCI) — RECRUITING
• Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD) — COMPLETED · PHASE2
• A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — ACTIVE_NOT_RECRUITING · PHASE2
• [18F]APN-1607 PET in Subjects With AD Compared to HC — COMPLETED · PHASE3
• Biomarkers of Cognitive Impairment in Blood Cells — COMPLETED
• Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects — OTHER · PHASE2
• Evaluation of Safety of Contraloid Acetate in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease — COMPLETED · PHASE1
• Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset — TERMINATED · PHASE3
• AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease — TERMINATED · PHASE3

Refine this search